Abstract

BackgroundHuman papilloma virus (HPV) infection was the main cause of cervical cancer. There were only a few reports and detailed data about epidemiological research of HPV infection in rural population of China.Materials and MethodsThe cervical cells of rural Chaozhou women were collected, and multiplex real time PCR was firstly performed to detect high-risk HPV (HR-HPV) infection, which could detect 13 types of HR-HPV (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68). Then, HPV-positive samples were typed by HPV GenoArray test.ResultsHR-HPV DNA was detected by multiplex real time-PCR in 3830 of 48559 cases (7.89%). There was a peak incidence in age of 55–60 years group, and a lower incidence in who lived in plain group compared with suburban, mountain and seashore group. 3380 cases of HPV positive sample were genotyped, 11.01% (372/3380) cases could not be classified, among the typed 3008 cases, 101 cases were identified without HR-HPV type infection, 2907 cases were infected with one HR-HPV type at least, the 6 most common HR-HPV types in descending order of infection, were type 52 (33.4%, 16 (20.95%), 58 (15.93%), 33 (9.94%), 68 (9.22%) and 18 (8.36%). The combined prevalence of HPV types 16 and 18 accounted for 28.52% of total infection. However, type 52 plus 58 presented 48.23% of total infection. 2209/2907 cases were infected with a single HPV type and 698/2907 cases were infected with multiple types, and multiple infection constituent ratio increased with age, with a peak incidence in age 55–60 years group.ConclusionsOur findings showed low prevalence of HPV vaccine types (16 and 18) and relatively high prevalence of HPV-52 and -58, support the hypothesis that the second-generation HPV vaccines including HPV-52 and -58 may offer higher protection for women in rural Guangdong Province.

Highlights

  • Cervical cancer is the second most common cancer in women, about 200 000 deaths yearly are caused by cervical cancer in the world [1]

  • There was a peak incidence in age of 55–60 years group, and a lower incidence in who lived in plain group compared with suburban, mountain and seashore group. 3380 cases of Human papilloma virus (HPV) positive sample were genotyped, 11.01% (372/3380) cases could not be classified, among the typed 3008 cases, 101 cases were identified without high-risk HPV (HR-HPV) type infection, 2907 cases were infected with one HR-HPV type at least, the 6 most common HR-HPV types in descending order of infection, were type 52 (33.4%, 16 (20.95%), 58 (15.93%), 33 (9.94%), 68 (9.22%) and 18 (8.36%)

  • Women lived at the seashore had the highest prevalence of HR-HPV, the second was those lived in the mountain, the third was who lived in the suburban

Read more

Summary

Introduction

Cervical cancer is the second most common cancer in women, about 200 000 deaths yearly are caused by cervical cancer in the world [1]. Certain types of human papillomavirus (HPV) are recognized as the main cause of cervical carcinoma [2]. The development of a prophylactic vaccine against these infections appears to be the most promising way of controlling cervical neoplasia. There are two licensed HPV vaccines; Gardasil (HPV-6/11/16/18) and Cervarix (HPV-16/ 18), mainly against the two major cancer-causing types (HPV-16/ 18). These vaccines could reduce the economic burden associated with HPV-related benign lesions, and these vaccines are safe, well tolerated and highly immunogenic [4]. Human papilloma virus (HPV) infection was the main cause of cervical cancer.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call